611 Bcl-2 family protein expression in navitoclax-treated patients (pts) with lymphoid malignancies

Autor:	E. McKeegan, Myron S. Czuczman, J. Gerecitano, Owen A. O'Connor, Stephen K. Tahir, W. Wilson, Matthew R. Smith, B. Chyla, Andrew Krivoshik, Sari H. Enschede
Rok vydání:	2010
Předmět:	Cancer Research chemistry.chemical_compound Navitoclax Oncology chemistry business.industry Immunology Bcl-2 family Cancer research Medicine business Protein expression
Zdroj:	European Journal of Cancer Supplements. 8:192
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(10)72318-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5281bcf9f5803449f366deda4bcfdf81 https://doi.org/10.1016/s1359-6349(10)72318-1 Zobrazit plný text záznamu Full Text from ScienceDirect